Agentix Corp (AGTX)
0.0354
+0.01
(+54.13%)
USD |
OTCM |
May 17, 13:18
Agentix Total Liabilities (Quarterly): 2.958M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.958M |
| September 30, 2023 | 3.149M |
| June 30, 2023 | 2.983M |
| March 31, 2023 | 2.511M |
| December 31, 2022 | 1.975M |
| September 30, 2022 | 1.624M |
| June 30, 2022 | 1.253M |
| February 28, 2022 | 1.038M |
| November 30, 2021 | 0.7732M |
| August 31, 2021 | 0.6069M |
| May 31, 2021 | 0.3701M |
| February 28, 2021 | 0.2899M |
| November 30, 2020 | 0.0543M |
| August 31, 2020 | 0.0693M |
| May 31, 2020 | 0.0437M |
| February 29, 2020 | 0.0293M |
| November 30, 2019 | 0.0176M |
| August 31, 2019 | 0.1259M |
| May 31, 2019 | 0.1092M |
| Date | Value |
|---|---|
| February 28, 2019 | 0.0982M |
| November 30, 2018 | 0.0815M |
| August 31, 2018 | 0.0554M |
| May 31, 2018 | 0.0421M |
| February 28, 2018 | 0.108M |
| November 30, 2017 | 0.0877M |
| August 31, 2017 | 0.0722M |
| May 31, 2017 | 0.0496M |
| February 28, 2017 | 0.2908M |
| November 30, 2016 | 0.1737M |
| August 31, 2016 | 0.0037M |
| May 31, 2016 | 0.0009M |
| February 29, 2016 | 0.0009M |
| November 30, 2015 | 0.0008M |
| August 31, 2015 | 0.0074M |
| May 31, 2015 | 0.002M |
| February 28, 2015 | 0.0221M |
| November 30, 2014 | 0.0141M |
| August 31, 2014 | 0.0196M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0176M
Minimum
Nov 2019
3.149M
Maximum
Sep 2023
1.052M
Average
0.6069M
Median
Aug 2021
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.112M |
| Shareholders Equity (Quarterly) | -2.846M |